La radiochirurgia con Cyberknife nei gliomi "high grade"

Translated title of the contribution: Radiosurgery Cyberknife in high grade gliomas

L. Fariselli, L. Bianchi, M. De Santis, L. Brait, A. Bergantin, A. Boiardi, C. Marras, G. Broggi, I. Milanesi

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVE: to evaluate efficacy of Cyberknife radiosurgery in survival of patients with glioblastoma recurrent. MATERIAL AND METHODS: 15 patients with glioblastoma recurrent were treated with staged radiosurgery in May 2004 - January 2006. The mean KPS was 70. The median prescribed isodose was 75% and the median mean dose was 24 Gy in 3 fractions. RESULTS: The mean survival time is 20 months. No acute toxicity was observed. At 15 months from the date of radiosurgery one case of radionecrosis was detected. CONCLUSIONS: our study population confirms that staged radiosurgery is effective in local treatment of recurrent GBM without major acute toxicities.

Translated title of the contributionRadiosurgery Cyberknife in high grade gliomas
Original languageItalian
Pages (from-to)161-164
Number of pages4
JournalRivista Medica
Volume13
Issue number1
Publication statusPublished - Mar 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Radiosurgery Cyberknife in high grade gliomas'. Together they form a unique fingerprint.

Cite this